Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 3 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold
Author(s): David Power Added: 1 year ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report… View more

Intervention

Prevention & Chronic Conditions
Revolutionising Thrombosis Treatment in ACS, SSP and AF: Bridging the Gaps With Next Generation Anticoagulation Strategies
Author(s): Davide Capodanno , Sneha Shah Jain Added: 5 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more

Anticoagulation

Electrophysiology & Arrhythmia
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF
Author(s): Carolyn Lam , Jeffrey Weitz Added: 5 months ago
Hear from Prof Carolyn Lam and Prof Jeffrey Weitz as they share key take-home messages from ESC 2025.Filmed onsite, this peer-to-peer discussion distils the latest updates in thrombosis management for acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF).Register for the upcoming Q&A webinar, taking place on 6 October (14:00 EDT / 20:00 CEST), to put your… View more

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment in ACS, SSP and AF
Author(s): Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain Start date: Oct 06, 2025
Following the ESC 2025 symposium 'Revolutionising Thrombosis Treatment in ACS, SSP and AF – Bridging the Gaps With Next Generation Anticoagulation Strategies', this live Q&A webinar offers an exclusive chance to continue the conversation.Join Prof Carolyn Lam (Singapore, UK), Prof Jeffrey Weitz (Hamilton, CA) and Dr Sneha Shah Jain (Stanford, US) as they address your questions on stroke… View more

Anticoagulation

Electrophysiology & Arrhythmia
CRT 24: The ABSORB Trial
Author(s): David Power Added: 1 year ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the… View more

Intervention

Vascular Disease and Surgery
ACC 25 Late-Breaking Discussion: The API-Cat Study
Author(s): Harriette Van Spall , Isabelle Mahé Added: 10 months ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the… View more

Anticoagulation

Vascular Disease and Surgery
Job title: Director of Coronary Imaging and Atherosclerosis Research
Dr Yohinobu Onuma, MD, PhD is a leading expert in the field of noninvasive and invasive coronary imaging and novel coronary devices such as bioresorbable scaffolds. His expertise includes quantitative coronary angiography (2-dimensional, 3-dimensional and bifurcation-dedicated), Syntax Score and multi-slice computed tomography. He holds the position of professor of interventional cardiology at… View more
Job title: Interventional Cardiologist
DrMichael Haude is anInterventional Cardiologist atRheinlandklinkum, Neuss, DE. He is President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Board Member of the European Society of Cardiology (ESC). Dr Haude's interests include drug eluting stents, bioresorbable scaffolds, complex PCI, structural heart disease intervention and complication management… View more
Bill D Gogas
Research Area(s) / Expertise: Job title: Editor-in-Chief, US Cardiology Review
Dr Gogas has more than 10 years of clinical and research experience in cardiology/interventional cardiology. He is current faculty at Nanjing University in China and formerly held a position in the Division of Cardiology of Emory University School of Medicine at the rank of Instructor of Medicine. He received his PhD from Erasmus University, Rotterdam, in 2014 under the mentorship of Prof Patrick… View more